China Resources Pharmaceutical Group Limited (FRA:640)

Market Cap	3.59B
Revenue (ttm)	34.10B
Net Income (ttm)	440.83M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	8.15
Forward PE	7.69
Dividend	0.02 (3.01%)
Ex-Dividend Date	May 28, 2025

Volume	3,000
Average Volume	2,400
Open	0.5600
Previous Close	0.5550
Day's Range	0.5600 - 0.5600
52-Week Range	0.5250 - 0.8350
Beta	n/a
RSI	43.46
Earnings Date	Aug 25, 2025

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovas...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 72,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 640

Financial Performance

In 2024, FRA:640's revenue was 257.67 billion, an increase of 5.30% compared to the previous year's 244.70 billion. Earnings were 3.33 billion, a decrease of -13.57%.

Financial numbers in CNY